$OM

Gaeta Renee sold $20K of OM

Gaeta Renee (Chief Financial Officer) sold 4,543 shares of Outset Medical, Inc. (OM) at $4.39 on 2026-08-17.

Original reporting
SEC EDGAR · Gaeta Renee
Published Aug 18, 2026, 10:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 11:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OM
Neutral
medium confidence
Mentioned
$OM
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but this disclosure alone does not provide new operational, financial, or regulatory information about Outset Medical.

02

Market read

A CFO open-market sale of roughly $20k is disclosed, which may cause minor short-term sentiment noise but is not a fundamental catalyst.

03

What to watch

Insider sales can be scheduled around personal events and do not reveal whether the executive remains bullish via other holdings or options.

Relevance 3/10Novelty 3/10Timing: filed after-hours on 2026-08-18, reflecting the 2026-08-17 sale

Background

The filing is an SEC Form 4 insider transaction for Outset Medical, Inc., reported by the CFO.

Company-level read

Ticker impact

$OMNeutralMedium confidence
Context

Outset Medical CFO Gaeta Renee sold 4,543 shares of OM at $4.39 on 2026-08-17, totaling about $19,944.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.

Evidence & confidence

Form 4 provides a concrete transaction, but the disclosed size is modest relative to typical company market caps, and insider sales are often non-informational without additional context.

Market effects

No clear sector read-through from a single, modest insider sale.

None indicated.

None indicated.

Counterpoint

The absence of a cited 10b5-1 plan does not necessarily imply bearish information; CFOs may sell for diversification, taxes, or planned liquidity needs.

Key entities

  • Outset Medical, Inc.

    Company whose shares were sold by its CFO in the reported Form 4.

  • Gaeta Renee

    Chief Financial Officer who executed the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMMedAI 8/10

Outset Medical (OM) Q2 2026 Earnings Call Transcript

Outset Medical (OM) reported Q2 2026 revenue of $31.6 million, up 1% year over year and 14% sequentially. Console revenue was $9.5 million, up 6% YoY, while product revenue fell 5% to $21.9 million. Non-GAAP gross margin was 42.2%. Cash and investments were $151 million. Full-year revenue guidance is $125 million to $130 million.

$OMMed

Outset Medical Reports Second Quarter 2026 Results

Outset Medical, Inc. (OM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Outset Medical Reports Second Quarter 2026 Results San Jose, CA – August 6, 2026 – Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today

$AEMMed

Tuesday’s analyst upgrades and downgrades

National Bank Financial analysts revised precious-metals and copper forecasts ahead of Q2 earnings, citing realized gold at $4,508/oz and silver at $73/oz, and copper at $5.82/lb. They cut 2026 gold and silver assumptions and adjusted target prices for multiple miners, generally lower. TD Cowen upgraded First Quantum Minerals on a likely Cobre Panama restart by year-end.

$OMMed

Outset Medical, Inc. (OM): Results of Operations and Financial Condition

Outset Medical, Inc. (OM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-10.1 2 om-ex10_1.htm EX-10.1 EX-10.1 Exhibit 10.1 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THA

$OMMedAI 8/10

Osisko logs 3. 49 % copper at Gaspé project in Quebec

Osisko Metals (TSX: OM) began its 2026 drilling at the Gaspé copper project in Quebec, aiming to add mineralization within the planned Whittle pit. It reported hole 30-1196: 80m at 1.93% Cu from 196m, including 30m at 3.49% Cu from 224m. Scotia Capital said intercepts fall in modelled waste rock, potentially supporting resource conversion.